Company intelligence / Profile preview

Antria, Inc.

Indiana, Pennsylvania, United Statesantria.org ↗

Ownership: Public · ANTB
Employees: ~50
Development stage: Commercial

Overview

Antria specializes in developing innovative cellular therapies for cosmetic and chronic disease indications. The company provides clinical research, drug discovery, and medical device development services. No detailed public data on proprietary clinical results or pipeline stages was found[1][2][3][4].

Therapeutic areas: OtherDermatology
Modalities: Cellular therapies (cell-based therapies)
Industry: Biotech

Drug pipeline

1 asset

autologous stromal vascular fraction-enriched fat graft

Unknown

Partnerships

Collaborates with sponsors, CROs, medical centers, and pharmaceutical companies (specific partners not named)[4]

Financials

Market cap: $60.5M
Total revenue: $0
Enterprise value: $-47.2M

Beyond the preview

Go deeper on Antria, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antria, Inc..

Explore the full profile